← Back to screener

BIOLIFE SOLUTIONS INC BLFS

Rank #2160 · Nasdaq · $1.4B market cap
⚠ Going-concern flag — the auditor (GRANT THORNTON LLP) raised substantial doubt about this company's ability to continue operating in the latest filing. Read the actual filing before drawing conclusions.
Score
31.3
P/E
-20.2
P/B
3.78
ROE
-18.7%
Op. Margin
-25.3%
Debt Ratio
14%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★☆☆☆
Weak

P/E -20.2x, P/B 3.78x. Ranks in the top 68% of the universe.

Profitability ★☆☆☆☆
Poor

ROE -18.7%. Ranks in the top 82% of the universe.

Safety ★★★★☆
Excellent

Debt ratio 14%. Ranks in the top 11% of the universe. Under 100% is generally considered a safe level.

Growth ★☆☆☆☆
Poor

Revenue decline of 10.8% year over year. Ranks in the top 84% of the universe.

Safety is the relative strength · Profitability is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2011–$-0.0B$-0.0B$-0.0B–-139
2012–$-0.0B$-0.0B$-0.0B–-134
2013–$-0.0B$-0.0B$-0.0B–-140
2014–$-0.0B$-0.0B$-0.0B–-125
2015–$-0.0B$-0.0B$-0.0B–-16
2016–$-0.0B$-0.0B$0.0B–30
2017–$-0.0B$-0.0B$0.0B–48
2018$0.0B$-0.0B$-0.0B$0.0B-9.665
2019$0.0B$0.0B$-0.0B$-0.0B18.5-174
2020$0.0B$-0.0B$-0.0B$0.0B-0.8337
2021$0.0B$-0.0B$-0.0B$0.0B-0.8202
2022$0.0B$-0.0B$0.0B$0.0B-13.0176
2023$0.1B$-0.0B$-0.0B$0.2B-29.542
2024$0.1B$-0.0B$-0.1B$0.5B-7.816
2025$0.1B$-0.0B$-0.1B$0.4B-25.314

← See the full screener